Cravens & Co Advisors’s CME Group CME Stock Holding History

Cravens & Co Advisors’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,529	Closed	-$999K	–	64
2024 Q3	$999K	Sell	4,529 -317	-7%	-$65.6K	0.77%	29
2024 Q2	$953K	Buy	4,846 +1,021	+27%	+$211K	0.71%	35
2024 Q1	$823K	Buy	3,825 +81	+2%	+$17K	0.68%	32
2023 Q4	$788K	Sell	3,744 -29	-0.8%	-$6.19K	0.68%	34
2023 Q3	$755K	Buy	3,773 +14	+0.4%	+$2.78K	0.71%	33
2023 Q2	$697K	Buy	3,759 +87	+2%	+$16.1K	0.64%	39
2023 Q1	$703K	Buy	3,672 +17	+0.5%	+$3.07K	0.66%	36
2022 Q4	$615K	Buy	+3,655	New	+$635K	0.57%	34

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cravens & Co Advisors's CME Position: Q4 2024 in Review

Cravens & Co Advisors sold out of CME Group (CME) in Q4 2024, closing a stake of 4,529 shares — an estimated $999K sold.

Cravens & Co Advisors first reported a position in CME in Q4 2022 and held it in 8 quarters. The position peaked at $999K in Q3 2024. 1,500 funds tracked by Wall St. Rank hold CME as of Q4 2024.

Cravens & Co Advisors reported no remaining CME Group position as of Q4 2024 after selling out during the quarter.
Cravens & Co Advisors sold 4,529 CME Group shares in Q4 2024, an estimated $999K.
Cravens & Co Advisors first reported a position in CME Group in Q4 2022 and held it in 8 quarters.
Cravens & Co Advisors's CME Group position peaked at $999K in Q3 2024.
1,500 funds tracked by Wall St. Rank held CME Group as of Q4 2024.

Based on Cravens & Co Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.